205 related articles for article (PubMed ID: 17367410)
41. Clinical potential of targeting Bruton's tyrosine kinase.
Uckun FM
Int Rev Immunol; 2008; 27(1-2):43-69. PubMed ID: 18300055
[TBL] [Abstract][Full Text] [Related]
42. Expression profiling of chicken DT40 lymphoma cells indicates clonal selection of knockout and gene reconstituted cells.
Nawaz HM; Blomberg KEM; Lindvall JM; Kurosaki T; Smith CIE
Biochem Biophys Res Commun; 2008 Dec; 377(2):584-588. PubMed ID: 18930021
[TBL] [Abstract][Full Text] [Related]
43. Polo-like-kinase 1 (PLK1) as a molecular target to overcome SYK-mediated resistance of B-lineage acute lymphoblastic leukaemia cells to oxidative stress.
Uckun FM; Ozer Z; Qazi S; Tuel-Ahlgren L; Mao C
Br J Haematol; 2010 Mar; 148(5):714-25. PubMed ID: 19912216
[TBL] [Abstract][Full Text] [Related]
44. Inhibiting Bruton's Tyrosine Kinase in CLL and Other B-Cell Malignancies.
Lucas F; Woyach JA
Target Oncol; 2019 Apr; 14(2):125-138. PubMed ID: 30927175
[TBL] [Abstract][Full Text] [Related]
45. Identification of a Btk-BAG3 complex induced by oxidative stress.
Rosati A; Di Salle E; Luberto L; Quinto I; Scala G; Turco MC; Pascale M
Leukemia; 2009 Apr; 23(4):823-4. PubMed ID: 19212330
[No Abstract] [Full Text] [Related]
46. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev AO; Mao C; Uckun FM
Leuk Lymphoma; 2003 Jun; 44(6):1011-8. PubMed ID: 12854903
[TBL] [Abstract][Full Text] [Related]
47. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity.
Kawakami Y; Miura T; Bissonnette R; Hata D; Khan WN; Kitamura T; Maeda-Yamamoto M; Hartman SE; Yao L; Alt FW; Kawakami T
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3938-42. PubMed ID: 9108083
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites.
Himmelmann A; Thevenin C; Harrison K; Kehrl JH
Blood; 1996 Feb; 87(3):1036-44. PubMed ID: 8562928
[TBL] [Abstract][Full Text] [Related]
49. Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells.
Zhu DM; Uckun FM
Clin Cancer Res; 2000 Jun; 6(6):2456-63. PubMed ID: 10873099
[TBL] [Abstract][Full Text] [Related]
50. Discovery of a series of 2,5-diaminopyrimidine covalent irreversible inhibitors of Bruton's tyrosine kinase with in vivo antitumor activity.
Li X; Zuo Y; Tang G; Wang Y; Zhou Y; Wang X; Guo T; Xia M; Ding N; Pan Z
J Med Chem; 2014 Jun; 57(12):5112-28. PubMed ID: 24915291
[TBL] [Abstract][Full Text] [Related]
51. BTK mediated apoptosis, a possible mechanism for failure to generate high titer retroviral producer clones.
Islam TC; Brandén LJ; Kohn DB; Islam KB; Smith CI
J Gene Med; 2000; 2(3):204-9. PubMed ID: 10894266
[TBL] [Abstract][Full Text] [Related]
52. Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells.
Granato M; Chiozzi B; Filardi MR; Lotti LV; Di Renzo L; Faggioni A; Cirone M
Cancer Lett; 2015 Oct; 366(2):191-7. PubMed ID: 26184999
[TBL] [Abstract][Full Text] [Related]
53. Targeting Bruton's tyrosine kinase in B cell malignancies.
Hendriks RW; Yuvaraj S; Kil LP
Nat Rev Cancer; 2014 Apr; 14(4):219-32. PubMed ID: 24658273
[TBL] [Abstract][Full Text] [Related]
54. A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis.
Pandey MK; Gowda K; Sung SS; Abraham T; Budak-Alpdogan T; Talamo G; Dovat S; Amin S
Exp Hematol; 2017 Sep; 53():31-42. PubMed ID: 28647392
[TBL] [Abstract][Full Text] [Related]
55. Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.
Robak T; Robak E
Expert Opin Investig Drugs; 2012 Jul; 21(7):921-47. PubMed ID: 22612424
[TBL] [Abstract][Full Text] [Related]
56. Bruton's tyrosine kinase as a drug discovery target.
Pan Z
Drug News Perspect; 2008 Sep; 21(7):357-62. PubMed ID: 19259548
[TBL] [Abstract][Full Text] [Related]
57. Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells.
Zhu DM; Narla RK; Fang WH; Chia NC; Uckun FM
Clin Cancer Res; 1998 Dec; 4(12):2967-76. PubMed ID: 9865907
[TBL] [Abstract][Full Text] [Related]
58. Expression of Bruton's tyrosine kinase in B-cell neoplasms evaluated by flow cytometry.
Marcondes NA; Fernandes FB; Alegretti AP; Faulhaber GAM
Clin Exp Med; 2017 Nov; 17(4):499-504. PubMed ID: 28028621
[TBL] [Abstract][Full Text] [Related]
59. Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death.
Uckun FM; Tuel-Ahlgren L; Song CW; Waddick K; Myers DE; Kirihara J; Ledbetter JA; Schieven GL
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9005-9. PubMed ID: 1409597
[TBL] [Abstract][Full Text] [Related]
60. Regulation of oxidative stress-induced calcium release by phosphatidylinositol 3-kinase and Bruton's tyrosine kinase in B cells.
Qin S; Stadtman ER; Chock PB
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7118-23. PubMed ID: 10840066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
